Therapeutic effects of mesenchymal stem cells on renal ischemia-reperfusion injury: A matter of genetic transfer?

9Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Accumulating evidence indicates that the protective effect of mesenchymal stem cells in models of tissue injury is related to the endocrine/pcrine release of factors. The delivery of growth factors, cytokines, prostaglandins, enzymes or extracellular vesicles from mesenchymal stem cells to target cells may induce cell reprogramming and de novo expression of factors involved in tissue proliferation and repair. A recent paper showed that Wharton jelly-derived mesenchymal stem cells interact with injured renal tubular epithelial cells, inducing the expression of native and foreign hepatocyte growth factor necessary for renal repair and fibrogenesis inhibition. The genetic exchange between resident and mesenchymal stem cells, probably mediated through microvesicles, therefore appears instrumental in mesenchymal stem cell therapeutic effects. © 2013 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Bruno, S., & Bussolati, B. (2013). Therapeutic effects of mesenchymal stem cells on renal ischemia-reperfusion injury: A matter of genetic transfer? Stem Cell Research and Therapy. BioMed Central Ltd. https://doi.org/10.1186/scrt205

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free